Viewing StudyNCT00172107



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00172107
Status: COMPLETED
Last Update Posted: 2021-05-17
First Post: 2005-09-12

Brief Title: A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 50 75 and 100µg in the Treatment of Postmenopausal Osteoporosis
Sponsor: Shire
Organization: Takeda

Conditions & Keywords Data

Conditions:
Name
Osteoporosis
Keywords:
Name View
ALX1-11 View
Post-menopausal View
Osteoporosis View
Parathyroid Hormone View
PTH View